CD38 and acute myeloid leukemia: Using fluorescence-activated cell sorting (FACS), leukemic stem cells were isolated as a subpopulation of less than 0.2% of the total leukemic cells in AML patients with similar cell surface markers (CD34+CD38-) to normal hematopoietic stem cells [17,18].